Article
"Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.
Aging cell - 1 Mar 2020
Rao Chinthalapally V, Asch Adam S, Carr Daniel J J, Yamada Hiroshi Y
Abstract excerpt
The cell cycle and its regulators are validated targets for cancer drugs. Reagents that target cells in a specific cell cycle phase (e.g., antimitotics or DNA synthesis inhibitors/replication stress inducers) have demonstrated success as broad-spectrum anticancer drugs. Cyclin-dependent kinases (CDKs) are drivers of cell cycle transitions. A CDK inhibitor, flavopiridol/alvocidib, is an FDA-approved drug for acute...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
